Table 4 Factors affecting overall survival in patients undergoing curative resection (n = 86)
From: Raised CA19–9 and CEA have prognostic relevance in gallbladder carcinoma
Variables | n | Median survival (months) | 3 yr survival | 5 yr survival | P value (Log rank) | |
|---|---|---|---|---|---|---|
Age | ≤50 | 40 | 50 | 62.2% | 46.6% | 0.051 |
> 50 | 46 | 28 | 46.3% | 22.5% | ||
Sex | Female | 67 | 50 | 61.5% | 56.4% | 0.045 |
Male | 19 | 26 | 34.3% | 11.4% | ||
CEA | ≤4 | 35 | 49 | 64.1% | 42.8% | 0.041 |
> 4 | 33 | 26 | 41.8% | 12.5% | ||
CA19–9 | ≤37 | 59 | 49 | 66.6% | 40.0% | 0.019 |
> 37 | 27 | 24 | 29.6% | – | ||
T stage 1/2 | 52 | 50 | 74.5% | 49.7% | 0.001 | |
T stage 3/4 | 34 | 16 | 18.0% | 09% | ||
Node negative | 47 | 55 | 22.3% | 08% | 0.001 | |
Node positive | 39 | 24 | 77.4% | 57.5% | ||
LVI | No | 43 | 28 | 50.0% | 37.5% | 0.633 |
Yes | 17 | 26 | 30.3% | 30.3% | ||
PNI | No | 42 | 39 | 57.7% | 43.3% | 0.010 |
Yes | 18 | 16 | 15.7% | 15.7% | ||